Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Topicsrheumatological

Phys · rheumatological

Immunological Investigation Immunoglobulins Complement Flow Cytometry

Also known as Immunological Investigation Immunoglobulins Complement Flow Cytometry · immunological investigation immunoglobulins complement flow cytometry

Consultant-physician depth guide to Immunological Investigation Immunoglobulins Complement Flow Cytometry for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.

medium10 referencesUpdated 18 July 202611 min readVerification in progress

Practise this topic

  • 10 MCQs
  • SAQ
  • Viva
  • Case

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 2ABIM Internal Medicine

Red flags

  • Missed urgency or delayed escalation in Immunological Investigation Immunoglobulins Complement Flow Cytometry turns a salvageable presentation into preventable harm
  • Treating the label without confirming the mechanism leads to wrong therapy in Immunological Investigation Immunoglobulins Complement Flow Cytometry
  • Ignoring multimorbidity and drug interactions while managing Immunological Investigation Immunoglobulins Complement Flow Cytometry is a classic exam and clinical trap
  • Failing to document the shared plan and safety-net advice after Immunological Investigation Immunoglobulins Complement Flow Cytometry loses follow-through
  • Using recalled thresholds without a cited source is forbidden — verify before acting
On this page
Study tools

Your progress

Saved on this device.

Practise this topic

  • MCQ practice1
  • Short-answer question1
  • Viva station1
  • Clinical case1

Target exams

FRACP DWEFRACP DCEMRCP Part 2ABIM Internal Medicine

Red flags

  • Missed urgency or delayed escalation in Immunological Investigation Immunoglobulins Complement Flow Cytometry turns a salvageable presentation into preventable harm
  • Treating the label without confirming the mechanism leads to wrong therapy in Immunological Investigation Immunoglobulins Complement Flow Cytometry
  • Ignoring multimorbidity and drug interactions while managing Immunological Investigation Immunoglobulins Complement Flow Cytometry is a classic exam and clinical trap
  • Failing to document the shared plan and safety-net advice after Immunological Investigation Immunoglobulins Complement Flow Cytometry loses follow-through
  • Using recalled thresholds without a cited source is forbidden — verify before acting

The answer first

Immunological investigation is the laboratory complement to the clinical assessment of patients with suspected autoimmune, immunodeficiency, lymphoproliferative, or systemic inflammatory disease. The four pillars are: quantitation of immunoglobulins (IgG, IgA, IgM, IgE, and IgG subclasses), measurement of complement (C3, C4, CH50, AH50) and split products (C3d, C5a), phenotyping of peripheral blood lymphocytes by flow cytometry, and functional assays (lymphocyte proliferation, neutrophil oxidative burst, complement haemolytic activity). Each result has to be interpreted in the clinical context, and the FRACP candidate must be able to defend the choice, the limitations, and the interpretation of each test. [1] [10]

The consultant-level decision sequence is: (1) define the clinical syndrome (recurrent infection, autoimmunity, lymphadenopathy, vasculitis, immunodeficiency); (2) choose the laboratory test that discriminates the likely diagnoses; (3) interpret the result with attention to age-related reference ranges, analytical interferences, and the pre-analytical phase (sample handling, transport); and (4) integrate the laboratory picture with the clinical and histological findings before assigning a diagnosis or beginning treatment. [9] [10]

Physician Medicine Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship atlas.

Sign in to continueSee pricing
References10ShowHide
  1. [1]Dialynas DP, Wilde DB, Marrack P, Pierres A, et al. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity Immunol Rev, 1983.PMID 6195085
  2. [2]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
  3. [3]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
  4. [4]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906
  5. [5]Ye S, Li D, Liu F, Lei M, et al. In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations J Pharm Biomed Anal, 2018.PMID 29413980
  6. [6]Barth MJ, Mavis C, Czuczman MS, Hernandez-Ilizaliturri FJ Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma Clin Cancer Res, 2015.PMID 25964296
  7. [7]Guardiola FA, Gónzalez-Párraga MP, Cuesta A, Meseguer J, et al. Immunotoxicological effects of inorganic arsenic on gilthead seabream (Sparus aurata L.) Aquat Toxicol, 2013.PMID 23603147
  8. [8]Endres D, von Zedtwitz K, Nickel K, Runge K, et al. Association of rheumatological markers with neuronal antibodies, cerebrospinal fluid, electroencephalography, and magnetic resonance imaging findings in 224 patients with psychotic syndromes Brain Behav Immun, 2024.PMID 38599500
  9. [9]Barsalou J, Saint-Cyr C, Drouin E, Le Deist F, et al. High prevalence of primary immune deficiencies in children with autoimmune disorders Clin Exp Rheumatol, 2011.PMID 21345299
  10. [10]Seitz M, Villiger P [Value of laboratory diagnosis in inflammatory rheumatologic diseases] Praxis (Bern 1994), 2002.PMID 11845615

Test yourself

Practise what you just read

  • 10 MCQs
  • SAQ
  • Viva
  • Case
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine atlas, every exam format, one subscription.

  • Complete atlas for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousIgG4-Related DiseaserheumatologicalNextOsteoarthritisrheumatological